Asterand Incorporated

Asterand’s mission is to help medical researchers in the genomics and proteomics industries conquer diseases. We provide the products and services necessary for the development of new diagnostics and therapeutics

Contact Details: Hudson Webber Cancer Research Center, Lab 815 Detroit MI 48201-2013 United States of America Tel: 313 966 9122 Fax: 313 966 9191 Email: jwickenhei@asterand.com WWW: www.asrerand.com/

Loading...

Recent Publications by Asterand Incorporated:
Direct detection of herceptin/trastuzumab binding on breast tissue sections. The protooncogene product HER-2/neu is the target of the humanized...	26th January, 2007	Asterand, Detroit, MI 48202, USA.	J Histochem Cytochem. 2007 Jan;55(1):25-33. Epub 2006 Sep 6. DOI Direct Link

BioNews Results for Asterand Incorporated:
Lipoxen, ImmuPharma and Plant Impact confirmed for biotechnology investor event, October 15	Proactive Investors.co.uk:  Oct 12 2009 1:33PM Matching: asterand

Asterand Incorporated Patents:
US Patent No.	Title
7569602	Furan derivatives as EP.sub.4 receptor antagonists
7528157	EP.sub.4 receptor antagonists
7507754	EP.sub.4 receptor antagonists
7429607	5-HT.sub.2B receptor antagonists
7417068	EP.sub.4 receptor antagonists
→View more Asterand Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 382 times since April 2007, the link to the organisation's website has been followed 51 times

Recent Search Terms used to find this page: email asterand | .

Search for more companies in Detroit

Search for more companies in MI

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Asterand Incorporated